ChemoCentryx planning $60M follow-on

ChemoCentryx Inc. (NASDAQ:CCXI) said late Monday it plans to raise $60 million in a follow-on underwritten by JPMorgan and Goldman Sachs. ChemoCentryx's lead compound, vercirnon (formerly Traficet-EN)...